$0.54
▼ -3.5% Today
as of Oct 22, 16:45 ET
Last 30 days
Recent Press Releases & News
Aprea Therapeutics to Host Pre-ESMO Virtual Panel on the State of WEE1 Inhibition in Precision Oncology
Aprea Therapeutics to Present at October Conferences
Aprea Therapeutics to Present Updated Interim Phase 1 Data on WEE1 Inhibitor APR-1051 in an Oral Presentation at 38th EORTC-NCI-AACR Symposium
APRE earnings at a glance
Over its last 2 reports the stock rose the next day 1 time and fell 1, moving ±2.1% on average; after the most recent report on May 13, 2026 it moved -2.2%. APRE beat the consensus EPS estimate in 2 of its last 3 reported quarters. The share price of $0.54 sits near its 52-week low.
Overview
52-week range
$0.51
$1.57
3% of range
Avg surprise (last 3)
-97.2%
Avg reaction (last 2)
-0.1%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.07 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.22 | $-0.23 | +4.3% | +66.7% | -2.2% | earnings |
| Wed Nov 12, 2025 | Sep/2025 | $-0.47 | $-0.11 | -327.3% | — | — | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.53 | $-0.77 | +31.2% | — | — | earnings |
| Wed May 14, 2025 | Mar/2025 | $-0.66 | — | — | — | +2.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.64 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.58 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.67 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.86 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.87 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.34 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-4M | $-3M | — | $-3M | $-3M | $-4M | — | $-4M |
| Net income | $-4M | $-3M | — | $-3M | $-3M | $-4M | — | $-4M |
| EPS (diluted) | $-0.07 | $-0.22 | — | $-0.47 | $-0.53 | $-0.66 | — | $-0.64 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $41M | $46M | $15M | $14M | $17M | $19M | $23M | $26M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $42M | $47M | $16M | $14M | $17M | $20M | $24M | $26M |
| Total assets | $42M | $48M | $16M | $14M | $17M | $20M | $24M | $27M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $38M | $42M | $12M | $11M | $13M | $16M | $19M | $22M |
Implied volatility — last 90 days
No IV snapshots yet for APRE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.
Sector peers
APRE earnings FAQ
How does APRE stock usually react to earnings?
Across the last 2 reports the average next-day move was ±2.1%, up 1 times and down 1 times.